1. Home
  2. CAPR vs WTBA Comparison

CAPR vs WTBA Comparison

Compare CAPR & WTBA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CAPR
  • WTBA
  • Stock Information
  • Founded
  • CAPR 2005
  • WTBA 1893
  • Country
  • CAPR United States
  • WTBA United States
  • Employees
  • CAPR N/A
  • WTBA N/A
  • Industry
  • CAPR Biotechnology: Biological Products (No Diagnostic Substances)
  • WTBA Major Banks
  • Sector
  • CAPR Health Care
  • WTBA Finance
  • Exchange
  • CAPR Nasdaq
  • WTBA Nasdaq
  • Market Cap
  • CAPR 324.6M
  • WTBA 332.5M
  • IPO Year
  • CAPR N/A
  • WTBA N/A
  • Fundamental
  • Price
  • CAPR $6.28
  • WTBA $19.96
  • Analyst Decision
  • CAPR Strong Buy
  • WTBA Hold
  • Analyst Count
  • CAPR 8
  • WTBA 2
  • Target Price
  • CAPR $24.75
  • WTBA $21.75
  • AVG Volume (30 Days)
  • CAPR 1.4M
  • WTBA 33.3K
  • Earning Date
  • CAPR 08-11-2025
  • WTBA 10-23-2025
  • Dividend Yield
  • CAPR N/A
  • WTBA 5.01%
  • EPS Growth
  • CAPR N/A
  • WTBA 33.79
  • EPS
  • CAPR N/A
  • WTBA 1.70
  • Revenue
  • CAPR $13,392,150.00
  • WTBA $87,098,000.00
  • Revenue This Year
  • CAPR N/A
  • WTBA $24.40
  • Revenue Next Year
  • CAPR $6,061.53
  • WTBA $9.68
  • P/E Ratio
  • CAPR N/A
  • WTBA $11.74
  • Revenue Growth
  • CAPR N/A
  • WTBA 15.15
  • 52 Week Low
  • CAPR $3.98
  • WTBA $17.31
  • 52 Week High
  • CAPR $23.40
  • WTBA $24.85
  • Technical
  • Relative Strength Index (RSI)
  • CAPR 36.33
  • WTBA 60.68
  • Support Level
  • CAPR $6.17
  • WTBA $19.72
  • Resistance Level
  • CAPR $7.30
  • WTBA $20.13
  • Average True Range (ATR)
  • CAPR 0.43
  • WTBA 0.51
  • MACD
  • CAPR -0.11
  • WTBA 0.19
  • Stochastic Oscillator
  • CAPR 4.53
  • WTBA 92.77

About CAPR Capricor Therapeutics Inc.

Capricor Therapeutics Inc is a clinical-stage biotechnology company focused on the development of transformative cell and exosome-based therapeutics for treating Duchenne muscular dystrophy (DMD), a rare form of muscular dystrophy which results in muscle degeneration and premature death, and other diseases with high unmet medical needs. The company's product pipeline includes CAP-1002, deramiocel an allogeneic cardiac-derived cell therapy. Deramiocel is currently advancing through Phase 3 clinical development for the treatment of Duchenne muscular dystrophy. Through its proprietary StealthXTM platform, the group uses its exosome technology to conduct preclinical research focused on vaccinology, delivering oligonucleotides, proteins, and small molecules to treat.

About WTBA West Bancorporation

West Bancorp Inc is a United States-based company that offers a full range of deposit services, including checking, savings and money market accounts and time certificates of deposit. West Bank also offers online banking, mobile banking, and treasury management services, which help to meet the banking needs of its customers. Treasury management services offered to business customers include cash management, client-generated automated clearing house transactions, remote deposit, and fraud protection services. Also offered are merchant credit card processing and corporate credit cards. The bank operates only in the United States of America region.

Share on Social Networks: